drugset / Trial / NCT05229913

Effects of Esketamine on Postpartum Depression

NCT05229913

RandomizedSequentialDouble-blindTreatment

Summary

Different concentrations of Esketamine were used after cesarean section. Through the evaluation of postoperative psychological status and analgesic effect, the optimal dosage of Esketamine to exert the effects of depression and analgesia was analyzed.

Timeline

Start
2022-02-20
Primary completion
2022-09-30
Completion
2023-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Esketamine Other / unclassified 0.2 mg/kg Intravenous
Subject Esketamine Other / unclassified 0.4 mg/kg Intravenous
Subject Esketamine Other / unclassified 0.6 mg/kg Intravenous
Subject Esketamine Other / unclassified 0.8 mg/kg Intravenous
Background Sufentanil Other / unclassified 1 ug/kg Intravenous
Background flurbiprofen axetil Other / unclassified 200 mg Intravenous
Background flurbiprofen axetil Other / unclassified 200 ml Intravenous

Indications